Transient antiretroviral treatment during acute simian immunodeficiency virus infection facilitates long-term control of the virus

scientific article

Transient antiretroviral treatment during acute simian immunodeficiency virus infection facilitates long-term control of the virus is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1098/RSTB.2000.0639
P932PMC publication ID1692816
P698PubMed publication ID11186303
P5875ResearchGate publication ID12145354

P2093author name stringJ D Lifson
D Wodarz
M A Nowak
R A Arnaout
P2860cites workViral immune evasion due to persistence of activated T cells without effector functionQ24646943
Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremiaQ28254584
Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytesQ29616210
CD40 ligand-mediated interactions are involved in the generation of memory CD8(+) cytotoxic T lymphocytes (CTL) but are not required for the maintenance of CTL memory following virus infectionQ33783902
Containment of simian immunodeficiency virus infection: cellular immune responses and protection from rechallenge following transient postinoculation antiretroviral treatmentQ33799700
The role of antigen-independent persistence of memory cytotoxic T lymphocytesQ33879538
A new theory of cytotoxic T-lymphocyte memory: implications for HIV treatment.Q33905201
A critical role for neutralizing-antibody-producing B cells, CD4(+) T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: implications for adoptive immunotherapy of virus carriersQ36241631
Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques.Q36368095
The extent of early viral replication is a critical determinant of the natural history of simian immunodeficiency virus infectionQ36548993
Levels of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral therapyQ39595379
CD40L-deficient mice show deficits in antiviral immunity and have an impaired memory CD8+ CTL response.Q41898717
CD40 ligand is pivotal to efficient control of virus replication in mice infected with lymphocytic choriomeningitis virus.Q45753109
Exhaustion of CTL memory and recrudescence of viremia in lymphocytic choriomeningitis virus-infected MHC class II-deficient mice and B cell-deficient miceQ45768069
Population dynamics of immune responses to persistent viruses.Q52306851
Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNAQ56930699
Characterization of HIV-1-specific T-helper cells in acute and chronic infectionQ77323949
Association of HLA profiles with early plasma viral load, CD4+ cell count and rate of progression to AIDS following acute HIV-1 infection. Multicenter AIDS Cohort StudyQ77619334
P433issue1400
P407language of work or nameEnglishQ1860
P921main subjectSimian immunodeficiency virusQ1890246
anti-retroviral agentQ50430310
P1104number of pages9
P304page(s)1021-1029
P577publication date2000-08-01
P1433published inPhilosophical Transactions of the Royal Society BQ2153239
P1476titleTransient antiretroviral treatment during acute simian immunodeficiency virus infection facilitates long-term control of the virus
P478volume355

Reverse relations

cites work (P2860)
Q35003539AIDS vaccines and preexposure prophylaxis: is synergy possible?
Q95785042An intrinsic way of multiclassification of endogenous psychoses. A follow-through investigation/Budapest 2000/based upon Leonhard's classification
Q36481186Ecological and evolutionary principles in immunology
Q36343536HIV vaccine design: insights from live attenuated SIV vaccines
Q37801269Human immunodeficiency virus-1 vaccine design: where do we go now?
Q43213534Immunity and protection by live attenuated HIV/SIV vaccines
Q41982002Infection of HIV-specific CD4 T helper cells and the clonal composition of the response
Q47574091Mathematical Models of HIV Latency
Q38255612Modeling T cell responses to antigenic challenge
Q21245370Modeling the within-host dynamics of HIV infection
Q33847673Role of CD8(+) lymphocytes in control of simian immunodeficiency virus infection and resistance to rechallenge after transient early antiretroviral treatment
Q21558500Safety and adherence to intermittent pre-exposure prophylaxis (PrEP) for HIV-1 in African men who have sex with men and female sex workers
Q52053599The role of antigenic stimulation and cytotoxic T cell activity in regulating the long-term immunopathogenesis of HIV: mechanisms and clinical implications.
Q44589651Transient early post‐inoculation anti‐retroviral treatment facilitates controlled infection with sparing of CD4+ T cells in gut‐associated lymphoid tissues in SIVmac239‐infected rhesus macaques, but not resistance to rechallenge
Q36026242Using mathematical modeling and control to develop structured treatment interruption strategies for HIV infection
Q34328792Viral dynamics during structured treatment interruptions of chronic human immunodeficiency virus type 1 infection

Search more.